A large number of research studies have been performed in all of Zenicor-EKG’s areas of application. These studies have established good diagnostic ability, in many cases clearly superior to conventional methods, and excellent results in terms of health economics. In addition to this, the research results have led to new, more efficient work methods for Healthcare.
The research has also developed a brand-new, effective method to prevent stroke with primary preventive atrial fibrillation screening, which has attracted a great deal of attention globally, both within the research community and externally.
Studies of Zenicor-EKG have been conducted at hospitals in Sweden, including Karolinska Institutet, Danderyd Hospital, Halland Hospital and Norrland University Hospital, as well as at Odense University Hospital in Denmark and Charité University Hospital in Germany. Further studies are currently in progress in Sweden, Norway, Denmark, Germany and the UK.